140 related articles for article (PubMed ID: 18555087)
1. Primary graft failure and Ca2+ sensitizers after heart transplantation.
Beiras-Fernandez A; Weis FC; Kur F; Kaczmarek I; Schmoeckel M; Weis M; Reichart B
Transplant Proc; 2008 May; 40(4):951-2. PubMed ID: 18555087
[TBL] [Abstract][Full Text] [Related]
2. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan treatment after primary organ failure in heart transplantation: a direct way to recovery?
Beiras-Fernandez A; Weis FC; Fuchs H; Meiser BM; Reichart B; Weis M
Transplantation; 2006 Oct; 82(8):1101-3. PubMed ID: 17060860
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan for primary graft failure after heart transplantation: a 3-year follow-up.
Beiras-Fernandez A; Kur F; Kaczmarek I; Frisch P; Weis M; Reichart B; Weis F
Transplant Proc; 2011; 43(6):2260-2. PubMed ID: 21839251
[TBL] [Abstract][Full Text] [Related]
5. The management of severe primary graft failure after cardiac transplantation.
Hauer D; Beiras-Fernandez A; Kur F; Weis M; Schmoeckel M; Weis FC
J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):203-5. PubMed ID: 18834785
[No Abstract] [Full Text] [Related]
6. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan reversing low output syndrome after heart transplantation.
Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
[TBL] [Abstract][Full Text] [Related]
8. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
Husedzinović I; Barisin S; Bradić N; Barisin A; Sonicki Z; Milanović R
Croat Med J; 2005 Dec; 46(6):950-6. PubMed ID: 16342349
[TBL] [Abstract][Full Text] [Related]
11. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan: a new therapeutic option in the treatment of primary graft dysfunction after heart transplantation.
Weis F; Beiras-Fernandez A; Kaczmarek I; Sodian R; Kur F; Weis M; Schmoeckel M; Reichart B
J Heart Lung Transplant; 2009 May; 28(5):501-4. PubMed ID: 19416780
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
15. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
Bredin F; Franco-Cereceda A
Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
[TBL] [Abstract][Full Text] [Related]
16. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
[TBL] [Abstract][Full Text] [Related]
17. Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy.
Guarracino F; Cariello C; Danella A; Doroni L; Lapolla F; Stefani M; Baldassarri R; Vullo C
Acta Anaesthesiol Scand; 2007 Oct; 51(9):1217-24. PubMed ID: 17850562
[TBL] [Abstract][Full Text] [Related]
18. Early experience with Levosimendan in children with ventricular dysfunction.
Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S
Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589
[TBL] [Abstract][Full Text] [Related]
20. How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure.
Schweigmann U; Velik-Salchner C; Kilo J; Schermer E
Artif Organs; 2011 Nov; 35(11):1105-9. PubMed ID: 21954874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
